Alpha 2.0
Login Register
» Articles » PMID: 34029238

Keratoplasty Rejection After the BNT162b2 Messenger RNA Vaccine

Overview
Journal Cornea
Specialty Ophthalmology
Date 2021 May 24
PMID 34029238
Citations 37
Authors
Lauren M Wasser
Eduardo Roditi
David Zadok
Liron Berkowitz
Yishay Weill
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this report was to report 2 patients who presented with acute corneal graft rejection 2 weeks after receiving the BNT162b2 messenger RNA (mRNA) vaccine for severe acute respiratory syndrome coronavirus 2.

Methods: Case report.

Results: Two men, aged 73 and 56 years, with a history of penetrating keratoplasty due to keratoconus were noted to have acute corneal graft rejection 2 weeks after receiving a first dose of the BNT162b2 mRNA vaccine. Both patients were treated with hourly dexamethasone 0.1% and oral prednisone 60 mg per day with prompt resolution of keratoplasty rejection.

Conclusions: The BNT162b2 mRNA vaccine may be have been associated with a low-risk corneal graft rejection that responded well to topical and systemic steroids. Treating physicians should be aware of this potential complication and patients should be advised to report any visual changes after vaccination.

Citing Articles

Ocular Implications of COVID-19 Infection and Vaccine-Related Adverse Events.

Parmar U, Surico P, Singh R, Musa M, Scarabosio A, Surico G J Pers Med. 2024; 14(8).

PMID: 39201972 PMC: 11355216. DOI: 10.3390/jpm14080780.

Mimickers of anterior uveitis, scleritis and misdiagnoses- tips and tricks for the cornea specialist.

Caplash S, Paez-Escamilla M, Westcott M, Dansingani K, Indermill C, Kisma N J Ophthalmic Inflamm Infect. 2024; 14(1):14.

PMID: 38594487 PMC: 11004105. DOI: 10.1186/s12348-024-00396-z.

COVID-19 vaccination and corneal allograft rejection- a review.

Allen N, Zhang J, McGhee C Front Cell Infect Microbiol. 2024; 13:1307655.

PMID: 38162575 PMC: 10757323. DOI: 10.3389/fcimb.2023.1307655.

COVID and COVID vaccine-related corneal morbidity: A review.

Sidhu N, Vanathi M, Gupta N, Tandon R Indian J Ophthalmol. 2023; 71(12):3595-3599.

PMID: 37991289 PMC: 10788745. DOI: 10.4103/IJO.IJO_765_23.

Corneal Adverse Events Associated with SARS-CoV-2/COVID-19 Vaccination: A Systematic Review.

Kuziez L, Eleiwa T, Chauhan M, Sallam A, Elhusseiny A, Saeed H Vaccines (Basel). 2023; 11(1).

PMID: 36680010 PMC: 9860789. DOI: 10.3390/vaccines11010166.

References
1.
Jhaveri R . The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?. Clin Ther. 2021; 43(3):549-556. PMC: 7825996. DOI: 10.1016/j.clinthera.2021.01.014. View
2.
Chong P, Avery R . A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients. Clin Ther. 2017; 39(8):1581-1598. DOI: 10.1016/j.clinthera.2017.07.005. View
3.
Hori J, Yamaguchi T, Keino H, Hamrah P, Maruyama K . Immune privilege in corneal transplantation. Prog Retin Eye Res. 2019; 72:100758. DOI: 10.1016/j.preteyeres.2019.04.002. View
4.
Mulley W, Dendle C, Ling J, Knight S . Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant. 2018; 37(7):844-852. DOI: 10.1016/j.healun.2018.03.001. View
5.
Solomon A, Frucht-Pery J . Bilateral simultaneous corneal graft rejection after influenza vaccination. Am J Ophthalmol. 1996; 121(6):708-9. DOI: 10.1016/s0002-9394(14)70638-5. View